Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001310967-13-000001
Filing Date
2013-03-26
Accepted
2013-03-25 19:25:13
Documents
1
Effectiveness Date
2013-03-26
Items
Item 06: Rule 506

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10729
  Complete submission text file 0001310967-13-000001.txt   11872
Mailing Address 1124 COLUMBIA ST SUITE 300 SEATTLE WA 98104
Business Address 1124 COLUMBIA ST SUITE 300 SEATTLE WA 98104 206-805-1617
Theraclone Sciences, Inc. (Filer) CIK: 0001310967 (see all company filings)

EIN.: 562442890 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-193896 | Film No.: 13715183